FOG2 coding variant Ser657Gly is associated with Coronary Microvascular Disease through altered hypoxia-mediated gene transcription
暂无分享,去创建一个
S. Tishkoff | D. Rader | J. Tobias | S. Damrauer | R. Judy | M. Levin | Z. Arany | M. Guerraty | D. Conlon | C. Zhang | Y.-A. Ko | S. Verma | Regeneron Genomics Center | M. McQuillan | J. W. Tobias | W. Haury | R. Judy | PennMedicine Biobank | S. Tishkoff | Z. Arany | M. McQuillan | W. Haury | Regeneron Genomics Center | PennMedicine Biobank
[1] Yun S. Song,et al. Whole-genome sequencing reveals a complex African population demographic history and signatures of local adaptation , 2023, Cell.
[2] G. Sirugo,et al. The Penn Medicine BioBank: Towards a Genomics-Enabled Learning Healthcare System to Accelerate Precision Medicine in a Diverse Population , 2022, Journal of personalized medicine.
[3] C. Yancy. The Journey Toward Health Equity: Are We Nearing an Abyss or Ascending a Peak? , 2021, Circulation.
[4] D. Mankoff,et al. The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes , 2020, PloS one.
[5] Swapan Mallick,et al. Insights into human genetic variation and population history from 929 diverse genomes , 2019, Science.
[6] F. F. Lunella,et al. High mitogenic stimulation arrests angiogenesis , 2019, Nature Communications.
[7] Akshay S. Desai,et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction , 2018, European heart journal.
[8] Christopher D. Brown,et al. Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. , 2017, Cell stem cell.
[9] P. Libby,et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.
[10] Pierre Tufféry,et al. PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex , 2016, Nucleic Acids Res..
[11] Ellen T. Gelfand,et al. A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project , 2015, Biopreservation and biobanking.
[12] W. Edwards,et al. Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction , 2015, Circulation.
[13] Euan A Ashley,et al. RNA-Seq identifies novel myocardial gene expression signatures of heart failure. , 2015, Genomics.
[14] S. Kelsey,et al. TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) , 2014, PloS one.
[15] M. Broman,et al. FOG-2 mediated recruitment of the NuRD complex regulates cardiomyocyte proliferation during heart development. , 2011, Developmental biology.
[16] W. Paulus,et al. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.
[17] Erik Jørgensen,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.
[18] S. Kong,et al. Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart. , 2009, The Journal of clinical investigation.
[19] F. Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[20] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Hirano,et al. Novel cell lines derived from adult human ventricular cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.
[22] B. Dallapiccola,et al. Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot , 2003, Human mutation.
[23] R. Aikawa,et al. Friend of GATA 2 Physically Interacts with Chicken Ovalbumin Upstream Promoter-TF2 (COUP-TF2) and COUP-TF3 and Represses COUP-TF2-dependent Activation of the Atrial Natriuretic Factor Promoter* , 2001, The Journal of Biological Chemistry.
[24] S. Orkin,et al. Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. , 2001, Genes & development.
[25] E. Svensson,et al. A Functionally Conserved N-terminal Domain of the Friend of GATA-2 (FOG-2) Protein Represses GATA4-Dependent Transcription* , 2000, The Journal of Biological Chemistry.
[26] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.